Trials / Recruiting
RecruitingNCT07250100
The Role of Microbiota in Pancreatic Cancer and Precursor Lesions
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Herlev Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response. Participants will be asked to complete a questionnaire, provide oral and fecal swabs, and-if clinically indicated-1-2 pancreatic biopsies will be collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observational study | Aprox. 300 patients suspected of pancreatic cancer. Of those, minimum of 50 patients with histologically confirmed PDAC in each of the stages I-II, III and IV, as some of the participants will be diagnosed with a non-malignant disease and will constitute the control group. |
Timeline
- Start date
- 2025-11-01
- Primary completion
- 2030-10-01
- Completion
- 2037-12-01
- First posted
- 2025-11-26
- Last updated
- 2025-11-26
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT07250100. Inclusion in this directory is not an endorsement.